UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
|
||||||
SCHEDULE
13D
Under
the Securities Exchange Act of 1934
|
||||||
(Amendment
No. )*
|
||||||
BioVeris
Corporation
|
||||||
(Name
of Issuer)
|
||||||
Common
Stock, $0.001 par value per share
|
||||||
(Title
of Class of Securities)
|
||||||
090676107
|
||||||
(CUSIP
Number)
|
||||||
Roche
Holding Ltd
Grenzacherstrasse
124
CH-4070
Basel
Switzerland
+41-61-688-1111
|
||||||
(Name,
Address and Telephone Number of Person Authorized to
Receive
Notices and Communications)
|
||||||
April
4, 2007
|
||||||
(Date
of Event which Requires Filing of this Statement)
|
||||||
If
the filing person has previously filed a statement on Schedule 13G
to
report the acquisition that is the subject of this Schedule 13D,
and is
filing this schedule because of §§240.13d-1(e), 240.13d-l(f) or
240.13d-l(g), check the following box. o
|
||||||
*The
remainder of this cover page shall be filled out for a reporting
person’s
initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information
which
would alter disclosures provided in a prior cover page.
|
||||||
The
information required on the remainder of this cover page shall not
be
deemed to be “filed” for the purpose of Section 18 of the Securities
Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions
of
the Act (however, see the Notes).
|
||||||
CUSIP
No.
090676107
|
||||||
1.
|
Names
of Reporting Persons.
I.R.S.
Identification Nos. of above persons (entities only).
Roche
Holding Ltd
|
|||||
2.
|
Check
the Appropriate Box if a Member of a Group (See Instructions)
(a)
o
|
|||||
3.
|
SEC
Use Only
|
|||||
4.
|
Source
of Funds (See Instructions)
N/A
|
|||||
5.
|
Check
if Disclosure of Legal Proceedings Is Required Pursuant to Items
2(d) or
2(e)
|
|||||
6.
|
Citizenship
or Place of Organization
Switzerland
|
|||||
NUMBER
OF SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING PERSON
WITH
|
7.
|
Sole
Voting Power
0
|
||||
8.
|
Shared
Voting Power
5,795,914
shares of Common Stock (including 332,000 shares subject to outstanding
options)(1)
|
|||||
9.
|
Sole
Dispositive Power
0
|
|||||
10.
|
Shared
Dispositive Power
0
|
|||||
11.
|
Aggregate
Amount Beneficially Owned by Each Reporting Person
5,795,914
shares of Common Stock(1)
|
|||||
12.
|
Check
if the Aggregate Amount in Row (11) Excludes Certain Shares (See
Instructions)
|
|||||
13.
|
Percent
of Class Represented by Amount in Row (11)
21.3%
|
|||||
14.
|
Type
of Reporting Person (See Instructions)
CO
|
ROCHE
HOLDING LTD
|
||
By:
|
/s/
Bruno Maier
|
|
Name: Bruno
Maier
|
||
Title: Director
|
||
By:
|
/s/
Beat Kraehenmann
|
|
Name: Beat
Kraehenmann
|
||
Title: Director
|
Name
and Business Address
|
Present
Principal Occupation Including Name and
Address of
Employer
|
|
Directors
|
||
Dr.
Franz B. Humer
|
Chairman
of the Board of Directors and Chief Executive Officer
|
|
Prof.
Dr Bruno Gehrig
Swiss Life Holding,
Swiss Life General-Guisan-Quai 40,
P.O. Box CH-8022, Zurich, Switzerland
|
Vice
Chairman and Independent Lead Director
Chairman
of Board of Directors of Swiss Life Holding (life insurance
company)
|
|
Andre
Hoffmann
|
Vice-Chairman
|
|
Prof.
Dr Pius Baschera
Hilti Aktiengesellschaft, Feldkircherstrasse 100,
Postfach 333, LI-9494 Schaan, Liechtenstein
|
Chairman
of the Board of Directors of Hilti Aktiengesellschaft (company which
sells
devices and systems for the construction and engineering
business)
|
|
Prof.
John Irving Bell
(Canadian citizen)
University of Oxford, University Offices,
Roosevelt Drive,
Headington, Oxford OX3 7DG, UK
|
Regius
Professor of Medicine, Oxford University
|
|
Peter
Brabeck-Letmathe
(Austrian citizen)
Nestle, S.A., Avenue Nestle,
CH-1800 Vevey, Vaud, Switzerland
|
Chairman
of the Board of Directors and Chief Executive Officer of Nestle,
S.A.
(global food company)
|
|
Lodewijk
J.R. de Vink
(American citizen)
Blackstone Healthcare Partners, LLC,
345 Park Avenue, New York, NY 10154
|
Founding
Member and Consultant of Blackstone Healthcare Partners, LLC (private
equity group)
|
|
Walter
Frey
Emil Frey Group, Badenerstrasse 600,
CH-8048 Zürich
|
Chairman
and Chief Executive Officer of Emil Frey Group (car dealing
company)
|
|
Dr.
DeAnne Julius
(British citizen)
Royal Institute of International Affairs,
Chatham House, 10 James’s Square,
London, SW1Y 4LE
|
Chairman,
Royal Institute of International Affairs (also known as Chatham House
which is an organization for the analysis of international
issues)
|
|
Dr.
Andreas Oeri
|
Surgeon
|
Name
and Business Address
|
Present
Principal Occupation Including Name and
Address of
Employer
|
|
Dr.
Wolfgang Ruttenstorfer
(Austrian)
OMV Aktiengesellschaft, Otto-Wagner-Platz 5,
A-1090 Wien
|
Chief
Executive Officer and Chairman of the Executive Board of OMV (Oil
and Gas
Group)
|
|
Prof.
Dr. Horst Teltschik
(German citizen)
|
None
|
|
Prof.
Dr. Beatrice Weder di Mauro
Johannes Gutenberg-Universität
FB03
Jakob Welderweg 4
D-55128 Mainz
|
Professor
of Economics at University of Mainz,
Mainz
|
Name
and Business Address
|
Present
Principal Occupation Including Name and
Address of
Employer
|
|
Executive
Officers
|
||
Dr.
Franz B. Humer
|
Chairman
and Chief Executive Officer
|
|
Dr.
Erich Hunziker
|
Chief
Financial Officer
|
|
William
M Burns
(British citizen)
|
Head
Pharmaceuticals Division
|
|
Dr.
Severin Schwan
|
Head
Diagnostics Division
|
|
Prof.
Jonathan K.C. Knowles
(British citizen)
|
Head
Global Research
|
|
Dr.
Gottlieb A. Keller
|
Head
Corporate Services and Human
Resources
|